Literature DB >> 15177065

Apomorphine delays simple reaction time in Parkinsonian patients.

Thomas Müller1, Sabine Benz, Horst Przuntek.   

Abstract

BACKGROUND: Parkinsonian patients have difficulty in the preparation and execution of movements, which translate into delayed performance of simple reaction time (SRT) paradigms.
OBJECTIVE: To examine short-term effects of an acute subcutaneous injection of the dopamine agonist apomorphine on the results of a SRT task.
METHODS: We studied a SRT paradigm in 26 non-fluctuating idiopathic Parkinsonian patients, before and 30, 60, 90 min after administration of apomorphine.
RESULTS: The reaction time (RT) was significantly delayed after apomorphine injection. We found no significant change in movement time (MT).
CONCLUSION: Delay of RT and the lack of response of MT to apomorphine administration may result from the sedative effects of apomorphine, overstimulation of postsynaptic dopaminergic receptors with subsequent inhibition of prefrontal cholinergic neurotransmission, and at least partial binding of apomorphine to presynaptic dopaminergic autoreceptors, which cause inhibition of locomotor activity. We suggest that future studies testing the capacity for reaction in Parkinsonian patients should consider the exact timing of the delivery of dopamine substituting drugs prior to the test.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 15177065     DOI: 10.1016/s1353-8020(01)00046-3

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  5 in total

Review 1.  Acute and chronic cognitive effects of levodopa and dopamine agonists on patients with Parkinson's disease: a review.

Authors:  Michele Poletti; Ubaldo Bonuccelli
Journal:  Ther Adv Psychopharmacol       Date:  2013-04

2.  Saccadic latency distributions in Parkinson's disease and the effects of L-dopa.

Authors:  A W Michell; Z Xu; D Fritz; S J G Lewis; T Foltynie; C H Williams-Gray; T W Robbins; R H S Carpenter; R A Barker
Journal:  Exp Brain Res       Date:  2006-03-17       Impact factor: 1.972

3.  Differential effects of dopaminergic therapies on dorsal and ventral striatum in Parkinson's disease: implications for cognitive function.

Authors:  Penny A Macdonald; Oury Monchi
Journal:  Parkinsons Dis       Date:  2011-03-06

4.  Amelioration of non-motor dysfunctions after transplantation of human dopamine neurons in a model of Parkinson's disease.

Authors:  M J Lelos; R J Morgan; C M Kelly; E M Torres; A E Rosser; S B Dunnett
Journal:  Exp Neurol       Date:  2016-02-04       Impact factor: 5.330

5.  Neurophysiological mechanisms of circadian cognitive control in RLS patients - an EEG source localization study.

Authors:  Rui Zhang; Moritz D Brandt; Wiebke Schrempf; Christian Beste; Ann-Kathrin Stock
Journal:  Neuroimage Clin       Date:  2017-06-15       Impact factor: 4.881

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.